# Endothelial Effects of Basal Insulin: Detemir Versus Glargine

> **NCT00699686** · PHASE4 · COMPLETED · sponsor: **University of Padova** · enrollment: 50 (estimated)

## Conditions studied

- Type 2 Diabetes
- Endothelial Dysfunction
- Cardiovascular Disease

## Interventions

- **DRUG:** Glargine
- **DRUG:** Detemir

## Key facts

- **NCT ID:** NCT00699686
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699686, "Endothelial Effects of Basal Insulin: Detemir Versus Glargine". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00699686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*